Overview

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blind study of the tolerability of three different doses of rifapentine
Phase:
Phase 2
Details
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborators:
US Department of Veterans Affairs
VA Office of Research and Development
Treatments:
Rifampin
Rifapentine